BioFortis
BioFortis is described as a private precision medicine software solutions provider based in Columbia, United States. Its operational data ties to laboratory services and AI-enabled clinical trial workflow tooling serving pharmaceutical and biotechnology sponsors.
- Company typePublic
- Founded2002
- HeadquartersColumbia, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What BioFortis does
BioFortis is described in firmographic data as a private precision medicine software solutions provider, founded in 2002 and headquartered in Columbia, United States, with 11-50 employees. The substantive source material provided relates to IQVIA Laboratories (IQVIA's laboratory services division), and the recorded legal name for BioFortis in the source resolves to "IQVIA," which suggests a corporate affiliation; the data does not, however, contain direct BioFortis-specific operational facts.
Based on the available source content, the documented operating profile centers on a B2B enterprise service platform spanning central laboratory services, digital technologies (including Labmatrix clinical trial sample management), a clinical genomics laboratory, discovery sciences, bioanalytical laboratories with LC-MS capabilities, biomarker services, and vaccine laboratory services. The core technology stack combines specialty lab services with next-generation lab technologies, including an AI-driven digital pathology capability delivered through a strategic collaboration with OracleBio, and an e-Requisition workflow product (Site Lab Navigator) for sponsors and investigator sites.
The go-to-market is enterprise field sales targeting pharmaceutical and biotechnology companies across drug discovery and development stages, delivered through a horizontal segmentation approach. Pricing is not publicly disclosed and is negotiated via direct consultation, consistent with a B2B services model that monetizes per-study, per-specimen, and per-assay engagements rather than seat-based subscription software. Marketing leverages industry conferences, webinars, thought leadership content, and a dedicated careers portal, while distribution is direct-to-enterprise.
BioFortis firmographics
Firmographics- Name
- BioFortis
- Legal name
- IQVIA
- Website
- https://biofortis.com
- Company type
- Public
- Founded year
- 2002
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- BioFortis is described as a private precision medicine software solutions provider based in Columbia, United States. Its operational data ties to laboratory services and AI-enabled clinical trial workflow tooling serving pharmaceutical and biotechnology sponsors.
- Ownership category
- akta.pro rank
BioFortis industry classification
Industry- Product category
- Precision Medicine Software
- NAICS
- Software Publishers (51321)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Sample / Biorepository & Biobank Informatics (Chain-of-Custody) (HLAGAJAH)
- akta.pro secondary industries
- Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM), Bioinformatics & Multi-omics Analysis Software (HLAGAJAD)
Keywords
Where BioFortis is headquartered
LocationHeadquarters
- HQ city
- Columbia
- HQ country
- United States
- HQ region
- North America
Markets served
BioFortis business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Revenue model
- Laboratory Services: Provides comprehensive central laboratory services, specialty biomarker services, bioanalytical services, and vaccine laboratory services to pharmaceutical and biotech companies throughout drug discovery and development stages
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
BioFortis product offering
Product offeringCore offering
BioFortis provides precision medicine software solutions that support translational and clinical research workflows, including analytics and data management for biomarker and genomics-driven studies. The company's offering is aimed at pharmaceutical, biotechnology, and academic research teams that need software infrastructure to manage and analyze precision medicine data.
Product overview
IQVIA Laboratories is a global leader in drug discovery and development laboratory services, offering a comprehensive suite of central laboratory and specialty biomarker services. The portfolio includes Central Laboratory Services, Digital Technologies (including Labmatrix for clinical trial sample management), Clinical Genomics Laboratory, Discovery Sciences, Bioanalytical Laboratories (with LC-MS capabilities for small and large molecules), Biomarker Services, and Vaccine Laboratory Services. The company operates as an integrated platform combining in-depth scientific expertise, operational excellence, and next-generation lab technologies to support pharmaceutical and biotech clients throughout drug discovery and development stages.
Differentiator
Problem solved
Functional benefit
Companies that use BioFortis
Customer profileSegments2 records
Ideal customer profiles1 record
BioFortis technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability1 record
Feature2 records
BioFortis partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- OracleBiocoreIQVIA Laboratories has formed a strategic collaboration with OracleBio to advance AI-driven digital pathology. The partnership integrates OracleBio's advanced AI image analysis capabilities to enhance clinical insights in digital pathology, improving the company's service offerings for pharmaceutical and biotech clients.
Scale indicators1 record
Recent moves4 records
Expansion highlights5 records
BioFortis competitors and assessment
Company assessmentDirect peers
- Veeva Systems: Veeva's Vault CDMS, Vault EDC, and Vault CTMS are the closest direct peers to BioFortis for pharma clinical-trial and lab data management, including sample tracking integrations. Both sell regulated, sponsor-grade software into the same pharma/biotech buyer.
- Medidata (Dassault Systèmes): Medidata's Rave EDC/CTMS and biospecimen management capabilities compete head-to-head with Labmatrix-style sample-management software in sponsor clinical-trial deployments, and target the same precision-medicine and biomarker-driven trial designs.
- Benchling: Benchling is a cloud life-sciences R&D platform covering sample/biomolecule management, registry, and traceability — directly adjacent to BioFortis Labmatrix for translational and biomarker workflows in pharma and biotech.
- LabVantage Solutions: LabVantage provides LIMS and biobank/ biorepository informatics for regulated life-sciences labs, directly mirroring BioFortis's chain-of-custody and sample-tracking core.
- STARLIMS (Abbott): STARLIMS is an established clinical/research LIMS used by hospital and biobank labs; it competes with Labmatrix in regulated laboratory informatics and sample management.
Broad incumbents
- Oracle Health Sciences (Clinical One / Siebel CTMS): Oracle offers a broad eClinical/CTMS suite aimed at pharma sponsors; it is a broader incumbent than BioFortis but competes for the same translational informatics wallet, especially where lab/sample data integrate with EDC.
- Thermo Fisher SampleManager: Thermo Fisher's SampleManager LIMS bundles sample and biobank management into the instrument vendor's stack — a broader incumbent whose instrument-tied LIMS competes with Labmatrix at pharma/biotech biorepositories.
Emerging players
- Dotmatics: Dotmatics provides scientific informatics for biology R&D, including sample and registry tracking, positioning it as an emerging alternative to Labmatrix-style biorepository software inside translational programs.
- Arxspan (Bruker): Arxspan's electronic laboratory notebook and registry software targets biopharma research data, with sample and assay tracking features that overlap BioFortis's translational research and biorepository functionality.
Regional players
- Flatiron Health: Flatiron focuses on oncology-specific clinical and real-world data, complementing BioFortis's precision-medicine use cases with deep tumor profiling, and they often appear together in oncology translational programs.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
BioFortis social profiles
Digital presenceBioFortis financial estimates
Financial estimateRevenue estimate
Valuation estimate
BioFortis leadership team
Management profileNumber of profiles
BioFortis funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BioFortis M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BioFortis
What does BioFortis do?
BioFortis provides precision medicine software solutions that support translational and clinical research workflows, including analytics and data management for biomarker and genomics-driven studies. The company's offering is aimed at pharmaceutical, biotechnology, and academic research teams that need software infrastructure to manage and analyze precision medicine data.
Is BioFortis a public or private company?
BioFortis is a public company. It is classified as unknown and is currently operating.
When was BioFortis founded?
BioFortis was founded in 2002. It employs 11 to 50 people.
Where is BioFortis based?
BioFortis is headquartered in Columbia, United States, in the North America region.
How does BioFortis make money?
One revenue line is on record: laboratory Services.
Who are BioFortis's main competitors?
Direct peers on record are Veeva Systems, Medidata (Dassault Systèmes), Benchling, LabVantage Solutions and STARLIMS (Abbott). Broad incumbents are Oracle Health Sciences (Clinical One / Siebel CTMS) and Thermo Fisher SampleManager. Emerging players are Dotmatics and Arxspan (Bruker). Flatiron Health is listed as a regional player.
Does BioFortis have an API?
No public API is recorded for BioFortis.
What industry is BioFortis in?
BioFortis's product category is Precision Medicine Software. Its primary akta.pro industry code is HLAGAJAH, Sample / Biorepository & Biobank Informatics (Chain-of-Custody), with a secondary code of HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF). Its NAICS code is 51321 and its SIC code is 7372.